NEXIUM¿ — Class II drug recall D-1141-2015
Terminated recall by AstraZeneca Pharmaceuticals LP, reported 2015-06-24, distributed nationwide. Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bott
| Recall number | D-1141-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AstraZeneca Pharmaceuticals LP, Wilmington, DE, United States |
| Recall initiated | 2015-06-10 |
| Classified | 2015-06-18 |
| Reported by FDA | 2015-06-24 |
| Terminated | 2016-09-27 |
| Distributed | Nationwide (US) |
| Quantity | 34,524 bottles |
| Reason classes | labeling |
| NDC | 00186-5020-31 |
| Lot numbers | 05/17, FC0064 |
Product
NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.
Reason for recall
Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1141-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.